Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Manabu Inoue MD, PhD, FAHA, FESO, FWSO

Manabu Inoue MD, PhD, FAHA, FESO, FWSO

Vascular Neurologist and Chief of Stroke Care Unit, National Cerebral and Cardiovascular Center Suita, Osaka, Japan

Manabu Inoue graduated Showa Medical University School in Tokyo in 2002 and moved to Stanford Stroke Center from 2011 to 2014. Dr. Inoue is currently working at the National Cerebral and Cardiovascular Center in Japan as a Chief of Stroke Care Unit since 2016, participating in anti-coagulants trial and wake up stroke trials, and running the first tenecteplase trial in Japan. Dr. Inoue is also running many collaborations internationally. His focus is acute stroke imaging.


Dr. Inoue receives lecturer’s fees from Bayer, Daiichi Sankyo, Bristol-Myers Squibb, and Medico’s Hirata.